<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Combined Treatment with Rapamycin and Zoledronic Acid Retards Growth of Advanced Murine Hepatocellular Carcinoma Via Activation of Innate and Adaptive Immunity

Simple item page
dc.contributor.authorKhan, Muhammad Ashfaq, Jr.
dc.contributor.authorAslam, Misbah, Jr.
dc.contributor.authorQureshi, Muhammad Asif
dc.contributor.authorWeng, Shih Yen
dc.contributor.authorSenkowski, Marcel Sacha, Jr.
dc.contributor.authorSchuppan, Detlef
dc.date.accessioned2026-11-05T11:01:45Z
dc.date.issued2018
dc.description.pages205A-206A
dc.description.volume68
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10792
dc.identifier.wosWOS:000446020500342
dc.language.isoen
dc.publisherWILEY
dc.relation.conferenceAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
dc.relation.ispartofHEPATOLOGY
dc.subjectGastroenterology & Hepatology
dc.titleCombined Treatment with Rapamycin and Zoledronic Acid Retards Growth of Advanced Murine Hepatocellular Carcinoma Via Activation of Innate and Adaptive Immunity
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.endPage206A
oaire.citation.startPage205A
oaire.citation.volume68
person.identifier.ridAER-9743-2022

Files

Collections

WOS